Integral Health Asset Management, LLC Amicus Therapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$10.72 - $13.3 $879,040 - $1.09 Million	82,000 Added 26.89%	387,000 $4.86 Million
Q1 2023 May 09, 2023	SELL	$10.91 - $13.54 $240,020 - $297,880	-22,000 Reduced 6.73%	305,000 $3.38 Million
Q4 2022 Feb 13, 2023	BUY	$9.89 - $12.7 $1.95 Million - $2.5 Million	197,000 Added 151.54%	327,000 $3.99 Million
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $5.64 Million - $7.32 Million	-574,490 Reduced 81.55%	130,000 $1.36 Million
Q2 2022 Aug 03, 2022	BUY	$6.23 - $11.12 $2.99 Million - $5.34 Million	480,490 Added 214.5%	704,490 $7.57 Million
Q1 2022 May 12, 2022	BUY	$7.89 - $12.48 $386,610 - $611,520	49,000 Added 28.0%	224,000 $2.12 Million
Q4 2021 Feb 02, 2022	SELL	$9.82 - $12.44 $2.46 Million - $3.11 Million	-250,000 Reduced 58.82%	175,000 $2.02 Million
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $437,000 - $592,000	-50,000 Reduced 10.53%	425,000 $4.06 Million
Q2 2021 Aug 30, 2021	SELL	$8.71 - $10.72 $4.14 Million - $5.09 Million	-475,000 Reduced 50.0%	475,000 $4.58 Million
Q2 2021 Aug 13, 2021	BUY	$8.71 - $10.72 $8.27 Million - $10.2 Million	950,000 New	950,000 $9.16 Million

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.